NDC 71205-017

verapamil hydrochloride

Verapamil Hydrochloride

verapamil hydrochloride is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Verapamil Hydrochloride.

Product ID71205-017_a56062ad-d6ec-4335-b902-7ac80cecf3d4
NDC71205-017
Product TypeHuman Prescription Drug
Proprietary Nameverapamil hydrochloride
Generic NameVerapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2009-09-17
Marketing CategoryANDA / ANDA
Application NumberANDA078906
Labeler NameProficient Rx LP
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength240 mg/1
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71205-017-30

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-017-30)
Marketing Start Date2018-04-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71205-017-60 [71205001760]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-02

NDC 71205-017-90 [71205001790]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-02

NDC 71205-017-30 [71205001730]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-02

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE240 mg/1

OpenFDA Data

SPL SET ID:4ffa579e-1d85-4b3b-ae06-6a9334e0f9e1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897649
  • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]